Livzon Pharmaceutical Group ( (HK:1513) ) has provided an announcement.
Livzon Pharmaceutical Group Inc. announced the cancellation of share options under its 2022 Share Options Incentive Scheme. The cancellation affects a total of 6,667,795 share options that were not exercised due to unmet performance targets and expiration. This move concludes the company’s current share options under the First Grant and the Reserved Grant, potentially impacting the company’s incentive strategies and shareholder interests.
More about Livzon Pharmaceutical Group
Livzon Pharmaceutical Group Inc. operates in the pharmaceutical industry, focusing on the development, manufacturing, and sale of pharmaceutical products. The company is based in Zhuhai, China, and offers a range of healthcare solutions through its subsidiaries.
YTD Price Performance: -0.29%
Technical Sentiment Signal: Buy
Current Market Cap: $3.93B
For a thorough assessment of 1513 stock, go to TipRanks’ Stock Analysis page.